CROSSJECT (EPA:ALCJ) | WebDisclosure

Basculer en Français

9477	Companies
185475	Keywords
117817	Articles
99317	Press releases

Home
Companies
CROSSJECT

PRESS RELEASE

published on 09/22/2025 at 07:30, 2 months 13 days ago

CROSSJECT Secures Additional BARDA Funding for the Progressive Developmental and FDA Authorization of the ZEPIZURE® (ZENEO® Midazolam)
CROSSJECT secures $11.3 million BARDA funding for ZEPIZURE® development towards FDA authorization. Advances include validation batches and facility audit completion

BARDA Funding Crossject FDA Authorization ZEPIZURE Development Emergency Auto-injectors
PRESS RELEASE

published on 09/22/2025 at 07:30, 2 months 13 days ago

CROSSJECT obtient un financement supplémentaire de la BARDA pour soutenir le développement et l'autorisation par la FDA de ZEPIZURE®
CROSSJECT obtient un financement supplémentaire de 11,3 millions de dollars de la BARDA pour le développement de ZEPIZURE® approuvé par la FDA

FDA Financement Crossject ZEPIZURE BARDA
BRIEF

published on 07/01/2025 at 07:35, 5 months 4 days ago

Change of liquidity contract for CROSSJECT

Liquidity Euronext Pharmaceutical Contract Crossject
BRIEF

published on 07/01/2025 at 07:35, 5 months 4 days ago

Changement de contrat de liquidité pour CROSSJECT

Contrat Euronext Liquidité Pharmaceutique Crossject
PRESS RELEASE

published on 07/01/2025 at 07:30, 5 months 4 days ago

CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité
CROSSJECT annonce la cessation et la mise en œuvre d’un nouveau contrat de liquidité avec Rothschild Martin Maurel pour favoriser la liquidité des transactions. Détails du contrat et impacts sur le marché réglementé d'Euronext

Contrat De Liquidité Rothschild Martin Maurel Euronext Crossject ZENEO®
BRIEF

published on 06/24/2025 at 19:05, 5 months 10 days ago

CROSSJECT obtient une augmentation de capital de 5,7 millions d'euros

Augmentation De Capital Soumission À La FDA ZEPIZURE® Gemmes Venture Vatel Capital
BRIEF

published on 06/24/2025 at 19:05, 5 months 10 days ago

CROSSJECT Secures €5.7 Million in Capital Increase

Capital Increase FDA Submission ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE

published on 06/24/2025 at 19:00, 5 months 10 days ago

CROSSJECT announces a successful capital increase of €5.7 million following full exercise of the extension clause
CROSSJECT successfully completes a capital increase of €5.7 million through preferential subscription rights, benefiting from new investor support and Gemmes Venture, to advance ZEPIZURE® development

Capital Increase Crossject ZEPIZURE® Gemmes Venture Vatel Capital
PRESS RELEASE

published on 06/24/2025 at 19:00, 5 months 10 days ago

CROSSJECT annonce le vif succès de son augmentation de capital portée à 5,7 millions d’euros après exercice intégral de la clause d’extension
CROSSJECT annonce le vif succès de son augmentation de capital à 5,7 millions d’euros après exercice intégral de la clause d’extension pour ZEPIZURE®

Financement Augmentation De Capital Pharmaceutique Crossject ZEPIZURE
BRIEF

published on 06/11/2025 at 07:35, 5 months 24 days ago

CROSSJECT advances in the development of ZEPIZURE® Junior for children

Epilepsy Pediatrics Crossject Auto-injector ZEPIZURE Junior

Accesswire

Published on 12/05/2025 at 14:00, 1 hour 9 minutes ago

Ocean Power Technologies Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 14:00, 1 hour 9 minutes ago

Bonk, Inc. Highlights Major Ecosystem Milestone: Launch of Regulated BONK ETP on SIX Swiss Exchange
Published on 12/05/2025 at 02:35, 12 hours 34 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 12 hours 39 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 14 hours 9 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 14:22, 47 minutes ago

EQS-Adhoc: Jungheinrich AG: Jungheinrich expects to complete sale of its Russian subsidiary in 2026 and adjusts forecast for the 2025 financial year
Published on 12/05/2025 at 14:16, 52 minutes ago

Advanced Blockchain AG: Successful Completion of Token Generation Event of Portfolio company Talisman
Published on 12/05/2025 at 14:10, 59 minutes ago

The Kingdom of Saudi Arabia Launches a New Official Platform, "Saudi Properties", Ahead of the Non-Saudi Property Ownership Law
Published on 12/05/2025 at 13:45, 1 hour 24 minutes ago

BingX Introduces Recurring Buy to Help Users Ride Out Crypto Market Swings
Published on 12/05/2025 at 13:00, 2 hours 9 minutes ago

Zentra Group plc: Posting of Notice of Annual General Meeting

Les Echos

Published on 12/05/2025 at 13:58, 1 hour 11 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE
Published on 12/05/2025 at 08:45, 6 hours 24 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 6 hours 24 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 6 hours 27 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 20 hours 54 minutes ago

Résiliation d'une convention conclue entre actionnaires

View all LES ECHOS COMFI WIRE